Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid tumors. The rapid progression of PDAC results in an advanced stage of patients when diagnosed. However, the dynamic molecular mechanism underlying PDAC progression remains far from clear. Methods The microarray...
Main Authors: | Zongfu Pan, Lu Li, Qilu Fang, Yiwen Zhang, Xiaoping Hu, Yangyang Qian, Ping Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-018-0718-5 |
Similar Items
-
Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01) -
Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma
by: Yan Li, et al.
Published: (2020-01-01) -
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
by: Wu-Hu Zhang, et al.
Published: (2020-01-01) -
Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
by: Hong-Bin Li, et al.
Published: (2021-09-01) -
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
by: Run-Fen Cheng, et al.
Published: (2016-07-01)